//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Scavenger receptor CD163 detoxes #hemoglobin (Hb) via haptoglobin–Hb (Hp-Hb) uptake, but can also bind free Hb directly. Richard Zhou & @parasitematt.bsky.social solve the CD163-Hb structure to reveal that CD163 arms allow receptor promiscuity when Hp is absent @plosbiology.org 🧪 plos.io/4eOLuIv
28d
Our latest study of the scavenger receptor CD163, led by Richard Zhou. This follows our previous study of how CD163 uses its remarkable molecular architecture to bind haptoglobin-haemoglobin. We now show how its flexible arms allow haemoglobin binding, revealing how ligand promiscuity works.
Introducing our new blood-stage malaria vaccine immunogen based on the essential invasion protein PfCyRPA. By understanding where on PfCyRPA the best antibodies bind, we used structure guided design to generate PfCyRPA-EM, which contains only the epitopes of the best antibodies.
Check out our latest study on the PfRIPR protein, essential for the malaria parasite to get inside our blood cells. We show how antibodies block the function of PfRIPR by preventing its flexible hinges from bending, or by stopping it from compacting as part of its mechanism.
Read all about it here journals.plos.org/plosbiology/...
27d
We are very much looking forward to being @courbongautier.bsky.social’s new home!!
3mo
New vaccine immunogens coming next! This study was led by @brendanfarrell as part of a great collaboration with Joshua Tan and Andrew Cooper, who isolated the human antibodies. Read all about it: www.biorxiv.org/content/10.6...
This immunogen is cheap and easy to produce and elicits a high quality antibody response. Project led by @nawsadalam. Read all about it: link.springer.com/article/10.1...
4mo
27d
4mo
Excited about parasites? Love watching movies? Come join our Wellcome-funded project! Parasitology friends, please do share far and wide.
4mo
3mo
4mo
Structure-guided design of a PfCyRPA-based #vaccine against blood-stage #malaria ➡️ doi.org/10.1038/s44321-026-00376-x By N. Alam, @parasitematt.bsky.social and colleagues @ox.ac.uk @kavlioxford.bsky.social
PLOS Biology
The scavenger receptor CD163 detoxifies hemoglobin after erythrocyte lysis via haptoglobin–hemoglobin uptake, but can also bind free haemoglobin directly to prevent oxidative damage. This study solves...
journals.plos.org
Structural basis for hemoglobin scavenging by CD163 reveals mechanism of ligand promiscuity
Matt Higgins
Matt Higgins
3mo
Matt Higgins
Matt Higgins
The PfPCRCR complex is essential for invasion of human erythrocytes by the deadliest malaria parasite, Plasmodium falciparum . Antibodies against each subunit of PfPCRCR prevent erythrocyte invasion and the PfRH5 component is currently the most advanced blood-stage malaria vaccine. Central within PfPCRCR is PfRIPR. This complex molecule contains a core and a flexible tail and allows PfPCRCR to bridge the parasite and erythrocyte during invasion. In this study, we generated a small panel of human monoclonal antibodies against PfRIPR. We structurally characterised four PfRIPR tail-binding antibodies in complex with PfRIPR fragments. We show that growth-inhibitory antibody RP.012 induces a kink in the PfRIPR tail while non-inhibitory antibodies do not. Furthermore, we show that these four antibodies modulate each other, either through antagonism or by acting synergistically. These studies have implications for the design of PfRIPR-based vaccine immunogens and indicate that the tail of PfRIPR undergoes essential conformational changes during erythrocyte invasion. ### Competing Interest Statement J.T., A.C., and L.T.W. are coinventors on a provisional patent filed on the human mAbs described in this study (63/777,850). The other authors have no competing interests. Wellcome Trust, https://ror.org/029chgv08, 220797/Z/20/Z Medical Research Council, MR/Z505687/1 Gates Foundation, INV-078815
www.biorxiv.org
Effective vaccines against malaria are urgently required. All components of the PfPCRCR complex are essential for erythrocyte invasion by Plasmodium falciparum and are potential vaccine immunogens aga...
Dynamic hinge-motion of PfRIPR revealed by malaria invasion inhibitory antibodies
Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria - EMBO Molecular Medicine
link.springer.com
Matt Higgins
Video
Matt Higgins
Matt Higgins
Melissa Hart
EMBO Molecular Medicine
The HartLab is looking for a research assistant to support the exploration of red blood cell invasion by Plasmodium and Babesia parasites and the establishment of their distinct intracellular niches. For more information on this 4-year position follow the link below: www.jobs.ac.uk/job/DQH098/r...
4mo
Congratulations to the new Doctor of Philosophy @courbongautier.bsky.social on a spectacular PhD defense following a groundbreaking PhD! Thanks to external examiner Damian Ekiert from JHU and the rest of the examining committee. Next stop, Oxford University for a postdoctoral fellowship. 🇫🇷🇨🇦🇬🇧
5mo
John Rubinstein